A Study of Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of KAN-101 in Celiac Disease (ACeD-it)
Clinical trial NCT05574010 · TERMINATED
Trial details
- NCT number
- NCT05574010
- Sponsor
- Kanyos Bio, Inc., a wholly-owned subsidiary of Anokion SA
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-15
- Primary completion
- 2024-11-29
- Enrollment
- 128
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.